This article describes the use of double-stranded RNA (dsRNA)-mediated interference (RNAi) in Drosophila cell lines to study signal transduction pathways. The researchers demonstrate that RNAi is effective in generating "knock-out" phenotypes for specific proteins, allowing the dissection of biochemical signaling cascades. They use this technique to investigate the insulin signaling pathway, showing that inhibiting the expression of DSR1 (MAPKK) prevents the activation of downstream ERK-A (MAPK), while blocking ERK-A expression increases DSR1 activation. They also show that Drosophila AKT (DAKT) activation depends on the insulin receptor substrate, CHICO, and that blocking Drosophila PTEN results in DAKT activation. These findings confirm the consistency of RNAi with known steps in the pathway. The study extends RNAi to two other proteins, DSH3PX1 and Drosophila ACK (DACK), demonstrating that DACK is upstream of DSH3PX1 phosphorylation, making DSH3PX1 an identified downstream target of ACK-like tyrosine kinases. The researchers also show that RNAi is effective in various Drosophila cell lines, including S2, KC, and BG3-C6 cells, and that it can be used to study the effects of gene knock-out on protein expression and signaling pathways. The article discusses the mechanism of dsRNA-mediated gene silencing, noting that it is catalytic and does not function by titrating endogenous mRNA. It also highlights the advantages of using RNAi in Drosophila cell culture, including its technical simplicity, rapid results, and high reproducibility. The study concludes that RNAi is a powerful tool for dissecting complex biochemical signaling cascades and determining the function of genes identified from the Drosophila genome sequencing project.This article describes the use of double-stranded RNA (dsRNA)-mediated interference (RNAi) in Drosophila cell lines to study signal transduction pathways. The researchers demonstrate that RNAi is effective in generating "knock-out" phenotypes for specific proteins, allowing the dissection of biochemical signaling cascades. They use this technique to investigate the insulin signaling pathway, showing that inhibiting the expression of DSR1 (MAPKK) prevents the activation of downstream ERK-A (MAPK), while blocking ERK-A expression increases DSR1 activation. They also show that Drosophila AKT (DAKT) activation depends on the insulin receptor substrate, CHICO, and that blocking Drosophila PTEN results in DAKT activation. These findings confirm the consistency of RNAi with known steps in the pathway. The study extends RNAi to two other proteins, DSH3PX1 and Drosophila ACK (DACK), demonstrating that DACK is upstream of DSH3PX1 phosphorylation, making DSH3PX1 an identified downstream target of ACK-like tyrosine kinases. The researchers also show that RNAi is effective in various Drosophila cell lines, including S2, KC, and BG3-C6 cells, and that it can be used to study the effects of gene knock-out on protein expression and signaling pathways. The article discusses the mechanism of dsRNA-mediated gene silencing, noting that it is catalytic and does not function by titrating endogenous mRNA. It also highlights the advantages of using RNAi in Drosophila cell culture, including its technical simplicity, rapid results, and high reproducibility. The study concludes that RNAi is a powerful tool for dissecting complex biochemical signaling cascades and determining the function of genes identified from the Drosophila genome sequencing project.